{"id":"W4200159367","doi":"10.1016/j.ijrobp.2021.12.005","title":"An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate Cancer","year":2021,"lang":"en","type":"review","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Institutes of Health; Advanced Accelerator Applications; Bayer Fund; Penn State Hershey Cancer Institute; Janssen Pharmaceuticals; Penn State College of Medicine; AstraZeneca; Astellas Pharma US; Varian Medical Systems; American Cancer Society","keywords":"Medicine; Prostate cancer; Tolerability; Androgen deprivation therapy; Testosterone (patch); Agonist; Leuprorelin; Luteinizing hormone; Gonadotropin-releasing hormone; Internal medicine; Gonadotropin-releasing hormone antagonist; Adverse effect; Discontinuation; Oncology; Hormone antagonist; Hormone; Antagonist; Cancer; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008487619,0.0007540186,0.001959211,0.001900471,0.0001819926,0.000809835,0.001113825,0.0009842254,0.005505707],"category_scores_gemma":[0.001530575,0.0002892692,0.001585025,0.001749338,0.0002678705,0.0008995351,0.0005055178,0.001314256,0.001182592],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004620811,"about_ca_system_score_gemma":0.001128827,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001371918,"about_ca_topic_score_gemma":0.003314555,"domain_scores_codex":[0.9997043,0.00006986417,0.0000647854,0.00005304641,0.0000890181,0.00001887698],"domain_scores_gemma":[0.9994281,0.0003585393,0.00009587986,0.00001042369,0.00008381074,0.0000233075],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002275344,0.00006975749,0.0001430396,0.09279278,0.0007409833,0.0001529407,0.00004758676,0.0002804247,0.001029203,0.0008899459,0.04209847,0.8615274],"study_design_scores_gemma":[0.0002996611,0.0004355729,0.001622852,0.04260071,0.003786474,0.001623034,0.00005703712,0.0001400934,0.000555967,0.001003218,0.9478239,0.00005142222],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007343489,0.9991233,0.00006300952,0.0001612296,0.000165068,0.000008427822,0.00002975175,0.000003581933,0.0003722064],"genre_scores_gemma":[0.0005040136,0.9984645,0.0001676058,0.0004003324,0.0001284609,0.000009719749,0.00004461016,0.000001532193,0.0002792174],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005505707,"threshold_uncertainty_score":0.01841843,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07838809019743119,"score_gpt":0.4543259764692983,"score_spread":0.3759378862718671,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}